Jump Trading’s United Therapeutics UTHR Stock Holding History

Jump Trading’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,541	Closed	-$416K	–	579
2019 Q1	$416K	Buy	+3,541	New	+$413K	0.13%	163

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jump Trading's UTHR Position: Q2 2019 in Review

Jump Trading sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 3,541 shares — an estimated $416K sold.

Jump Trading first reported a position in UTHR in Q1 2019 and held it in 1 quarter. The position peaked at $416K in Q1 2019. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

Jump Trading reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 3,541 United Therapeutics shares in Q2 2019, an estimated $416K.
Jump Trading first reported a position in United Therapeutics in Q1 2019 and held it in 1 quarter.
Jump Trading's United Therapeutics position peaked at $416K in Q1 2019.
320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.